XML 23 R5.htm IDEA: XBRL DOCUMENT v3.25.2
EPT - Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Accumulated other comprehensive income, net
Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2023   64,203        
Balance at period beginning at Dec. 31, 2023 $ 5,593,978 $ 6 $ 6,656,720 $ (1,267,536) $ 33,556 $ 171,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 384,126     365,645   18,481
Change in fair value of derivatives and amortization of swap settlements 5,508       5,321 187
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   7        
Stock option and restricted stock plans, net 962   962      
Sale of common stock, net (113)   (113)      
Equity based compensation costs 3,743   3,616     127
Changes in the redemption value of redeemable noncontrolling interest (1,684)   (1,623)     (61)
Distributions to noncontrolling interest (17,075)         (17,075)
Redemptions of noncontrolling interest (279)   (249)     (30)
Common stock dividends (314,666)     (314,666)    
Balance at period end (in shares) at Jun. 30, 2024   64,210        
Balance at period end at Jun. 30, 2024 5,654,500 $ 6 6,659,313 (1,216,557) 38,877 172,861
Balance at period beginning (in shares) at Mar. 31, 2024   64,209        
Balance at period beginning at Mar. 31, 2024 5,723,753 $ 6 6,658,882 (1,152,136) 41,279 175,722
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 98,986     92,914   6,072
Change in fair value of derivatives and amortization of swap settlements (2,487)       (2,402) (85)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   1        
Stock option and restricted stock plans, net 0          
Sale of common stock, net (105)   (105)      
Equity based compensation costs 2,048   1,979     69
Changes in the redemption value of redeemable noncontrolling interest (1,697)   (1,443)     (254)
Distributions to noncontrolling interest (8,663)         (8,663)
Common stock dividends (157,335)     (157,335)    
Balance at period end (in shares) at Jun. 30, 2024   64,210        
Balance at period end at Jun. 30, 2024 5,654,500 $ 6 6,659,313 (1,216,557) 38,877 172,861
Balance at period beginning (in shares) at Dec. 31, 2024   64,280        
Balance at period beginning at Dec. 31, 2024 5,720,390 $ 6 6,668,047 (1,155,662) 24,655 183,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 444,304     424,472   19,832
Change in fair value of derivatives and amortization of swap settlements (13,521)       (13,064) (457)
Change in fair value of marketable debt securities, net 87       84 3
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   49        
Stock option and restricted stock plans, net 8,411   8,411      
Sale of common stock, net (101)   (101)      
Equity based compensation costs 4,414   4,264     150
Changes in the redemption value of redeemable noncontrolling interest (2,073)   (1,702)     (371)
Distributions to noncontrolling interest (16,485)         (16,485)
Redemptions of noncontrolling interest (in shares)   75        
Redemptions of noncontrolling interest (8,556)   6,795     (15,351)
Common stock dividends (330,956)     (330,956)    
Balance at period end (in shares) at Jun. 30, 2025   64,404        
Balance at period end at Jun. 30, 2025 5,805,914 $ 6 6,685,714 (1,062,146) 11,675 170,665
Balance at period beginning (in shares) at Mar. 31, 2025   64,358        
Balance at period beginning at Mar. 31, 2025 5,745,575 $ 6 6,672,346 (1,117,971) 15,620 175,574
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 231,526     221,362   10,164
Change in fair value of derivatives and amortization of swap settlements (4,149)       (4,013) (136)
Change in fair value of marketable debt securities, net 70       68 2
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   19        
Stock option and restricted stock plans, net 2,902   2,902      
Sale of common stock, net (101)   (101)      
Equity based compensation costs 2,359   2,279     80
Changes in the redemption value of redeemable noncontrolling interest 1,454   1,473     (19)
Distributions to noncontrolling interest (8,185)         (8,185)
Redemptions of noncontrolling interest (in shares)   27        
Redemptions of noncontrolling interest 0   6,815     (6,815)
Common stock dividends (165,537)     (165,537)    
Balance at period end (in shares) at Jun. 30, 2025   64,404        
Balance at period end at Jun. 30, 2025 $ 5,805,914 $ 6 $ 6,685,714 $ (1,062,146) $ 11,675 $ 170,665